Correlation Between Anteris Technologies and Applied Therapeutics

Can any of the company-specific risk be diversified away by investing in both Anteris Technologies and Applied Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anteris Technologies and Applied Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Anteris Technologies Global and Applied Therapeutics, you can compare the effects of market volatilities on Anteris Technologies and Applied Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anteris Technologies with a short position of Applied Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anteris Technologies and Applied Therapeutics.

Diversification Opportunities for Anteris Technologies and Applied Therapeutics

0.31

Correlation Coefficient

Anteris Technologies  Applied Therapeutics

Weak diversification

The 3 months correlation between Anteris and Applied is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Anteris Technologies Global and Applied Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Applied Therapeutics and Anteris Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anteris Technologies Global are associated (or correlated) with Applied Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Applied Therapeutics has no effect on the direction of Anteris Technologies i.e., Anteris Technologies and Applied Therapeutics go up and down completely randomly.

Pair Corralation between Anteris Technologies and Applied Therapeutics

Considering the 90-day investment horizon Anteris Technologies Global is expected to under-perform the Applied Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Anteris Technologies Global is 4.1 times less risky than Applied Therapeutics. The stock trades about -0.01 of its potential returns per unit of risk. The Applied Therapeutics is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  43.00  in Applied Therapeutics on September 16, 2025 and sell it today you would lose (31.00) from holding Applied Therapeutics or give up 72.09% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Anteris Technologies Global  vs.  Applied Therapeutics

Anteris Technologies

Risk-Adjusted Performance

Weakest

Over the last 90 days Anteris Technologies Global has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Anteris Technologies is not utilizing all of its potentials. The newest stock price agitation, may contribute to short-term losses for the retail investors.

Applied Therapeutics

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Applied Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating essential indicators, Applied Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Anteris Technologies and Applied Therapeutics

The main advantage of trading using opposite Anteris Technologies and Applied Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anteris Technologies position performs unexpectedly, Applied Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Applied Therapeutics will offset losses from the drop in Applied Therapeutics' long position.

The idea behind Anteris Technologies Global and Applied Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.